Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)

Abstract Peripheral T-cell lymphomas (PTCLs) are a group of highly aggressive malignancies with generally poor prognoses, and the first-line chemotherapy of PTCL has limited efficacy. Currently, several novel targeted agents, including histone deacetylase inhibitors (HDACis), have been investigated...

Full description

Bibliographic Details

Main Authors:	Guang Lu, Shikai Jin, Suwen Lin, Yuping Gong, Liwen Zhang, Jingwen Yang, Weiwei Mou, Jun Du
Format:	Artigo
Language:	Inglês
Published:	BMC 2023-08-01
Series:	Clinical Epigenetics
Subjects:	Histone deacetylase HDACi PTCL Romidepsin Belinostat Chidamide
Online Access:	https://doi.org/10.1186/s13148-023-01531-8
Tags:	Add Tag No Tags, Be the first to tag this record!